Results 51 to 60 of about 175,057 (155)

Comparative Outcomes of Consolidation Strategies After R‐MVP Induction in Primary Diffuse Large B‐Cell Lymphoma of the Central Nervous System

Cancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Background The optimal consolidation strategy following high‐dose methotrexate (MTX)–based induction in primary central nervous system lymphoma (PCNSL) remains controversial. This study compared real‐world outcomes of different consolidation modalities in patients responsive to rituximab, MTX, vincristine, and procarbazine (R‐MVP) induction ...
Sang‐A Kim, Jung Sun Kim, Ji Yun Lee, Joo Ho Lee, Keun‐Yong Eom, Chul‐Kee Park, Chae‐Yong Kim, Dae Seog Heo, Jeong‐Ok Lee, Tae Min Kim   +9 more
wiley   +1 more source

Intraocular dissemination or de novo disease? Distinguishing primary vitreoretinal lymphoma from secondary lymphoma

The Pan-American Journal of Ophthalmology
This report describes a rare case most consistent with presumed primary vitreoretinal lymphoma (PVRL) in a patient with a remote history of follicular B-cell lymphoma, highlighting the clinical, imaging, and systemic features that help distinguish PVRL ...
Guilherme Feltrin De Barros, Natalia Vila Grane, Eduardo Lobo da Rosa de Almeida, Jacqueline Coblentz, John Chen, Miguel Noel Burnier   +5 more
doaj   +1 more source

Primary Cilio-Choroidal Lymphoma with Epibulbar Extension

Delhi Journal of Ophthalmology, 2015
Primary intraocular lymphomas are rare malignancies and maybe either primary vitreoretinal lymphomas or primary uveal lymphomas. Though primary vitreoretinal lymphomas are increasingly being recognized, primary uveal lymphomas remain a very rare entity ...
Shahana Mazumdar, Uma Sridhar, Tushar Sardana, Gagan Saini   +3 more
doaj   +1 more source

Methotrexate‐Loaded Liposomal Formulation Enables 6‐Week Sustained Intraocular Therapeutic Drug Release in a Porcine Model

Advanced Healthcare Materials, Volume 15, Issue 1, 9 January 2026.
A liposomal formulation for methotrexate enables minimally invasive, sustained intraocular drug delivery for over six weeks with a single injection. Developed for treating intraocular diseases like lymphoma and PVR, it offers excellent biocompatibility in vivo in a porcine model.
Maximilian Hammer, Lea Skrzypczyk, Sabrina Wohlfart, Bryan Calder Ackermann, Ludwig Geisweid, Simon William Pohl, Margarita Karaivanova, Jonathan Herth, Victor Aristide Augustin, Alexander Studier‐Fischer, Tina Sackmann, Leon Kaulen, Anna Steyer, Walter Mier, David H Steel, Kanmin Xue, Gerd Uwe Auffarth, Philipp Uhl   +17 more
wiley   +1 more source

Capillary Dropout: A Novel Fluorescein Angiography Finding in Primary Vitreoretinal Lymphoma

, 2017
Tissue diagnosis with vitreous and/or retinal biopsy usually confirms the diagnosis of primary vitreoretinal lymphoma. Multiple imaging modalities like fundus fluorescein angiography, fundus autofluorescence, and optical coherence tomography have been ...
Ramesh Venkatesh, Prachi Gurav, Arpan Gandhi, Prachi Abhishek Dave   +3 more
core   +1 more source

Additional file 2 of Targeting Bruton’s tyrosine kinase in vitreoretinal lymphoma: an open-label, prospective, single-center, phase 2 study

, 2022
Additional file 2: Table S2.
Liang Wang (23021), Wenxue Guan (14078884), Xiaoyan Peng (3816460)   +2 more
core   +1 more source

Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate

BMC Ophthalmology, 2022
Background To identify retinal changes using spectral-domain optical coherence tomography (SD-OCT) and ultra-widefield images in eyes with primary vitreoretinal lymphoma (PVRL) during intravitreal methotrexate (MTX) treatment.
Tingting Jiang, Junxiang Gu, Shixue Liu, Qing Chang   +3 more
doaj   +1 more source

Acute Retinal Detachment Following Ozurdex Implant in a Nonvitrectomized Eye

Case Reports in Ophthalmological Medicine, Volume 2026, Issue 1, 2026.
Intravitreal injection (IVI) of antivascular endothelial growth factors and dexamethasone implants are among the most performed procedures in ophthalmology, as they are used to treat various retinal diseases. Although considered safe, some rare but sight‐threatening complications can occur, like endophthalmitis and retinal detachment. Here, we report a
Abdullah Alkhamees, Khaled Alsabah, Alexander Bialasiewicz   +2 more
wiley   +1 more source

Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma

International Journal of Retina and Vitreous, 2021
Purpose To describe the visual acuity and anatomic outcomes of intravitreal methotrexate (MTX) for the treatment of primary vitreoretinal lymphoma (PVRL).
Casey L. Anthony, J. Clay Bavinger, Jessica G. Shantha, Ghazala D. O’Keefe, William A. Pearce, Alfredo Voloschin, Hans E. Grossniklaus, Steven Yeh   +7 more
doaj   +1 more source

Long‐Term Real‐World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results

Hematological Oncology, Volume 43, Issue 6, November 2025.
ABSTRACT Primary central nervous system lymphomas (PCNSL) are rare malignancies with poor survival outcomes. The IELSG32 trial demonstrated efficacy of MATRix chemoimmunotherapy followed by autologous stem cell transplantation (auto‐SCT) in PCNSL patients aged ≤ 70 years with a performance status (PS) ECOG ≤ 3.
Prokop Vodicka, Andrea Janikova, David Belada, Veronika Hanackova, Heidi Mocikova, Juraj Duras, Katerina Steinerova, Katerina Benesova, Eva Konirova, Tomas Prochazka, Kamila Polgarova, Michal Masar, Jitka Dlouha, Petra Blahovcova, Marek Trneny   +14 more
wiley   +1 more source